Outsourcing Pharma
DECEMBER 13, 2021
The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.
Fierce Healthcare
DECEMBER 13, 2021
Insurtech platform HealthCare.com banks $180M, boosts valuation to $1B. rtorrence. Mon, 12/13/2021 - 15:15.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 15, 2021
Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. But the difference between them is not like the choice between “agreeing” and “aligning” or “getting together later” and “taking this offline.” Going from the vital activity of patient engagement to the more encompassing state of patient centricity requires big steps in the evolution of new-drug discovery, development, and delivery.
Pharma Marketing Network
DECEMBER 17, 2021
The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. In this article, R.J. Lewis, Founder & CEO of eHealthcare Solutions and Tap Native, offers his top ten predictions for what’s ahead for pharma in 2022.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Outsourcing Pharma
DECEMBER 13, 2021
Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.
Fierce Healthcare
DECEMBER 17, 2021
Oracle in talks to buy Cerner in potential $30B deal: WSJ. hlandi. Fri, 12/17/2021 - 07:56.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Marketing Network
DECEMBER 17, 2021
Big pharma has compelling reasons to change the way business gets done. The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. Leaders are hard at work focusing their efforts on how to use sustainability as a platform for innovation. Step one is to assess your corporate social responsibility (CSR) policies and ensure actions are integrated across the organization.
Outsourcing Pharma
DECEMBER 15, 2021
The artificial intelligence-driven drug discovery company has dosed its first healthy volunteer in a trial for a candidate to treat idiopathic pulmonary fibrosis.
Fierce Healthcare
DECEMBER 12, 2021
Hospitals across the country running out of beds, reducing surgeries amid latest COVID surge. hlandi. Sun, 12/12/2021 - 22:15.
pharmaphorum
DECEMBER 17, 2021
A judge in the US has rejected the bankruptcy plan proposed by Purdue Pharma to settle legal action over its role in the opioid crisis , because of the protection from civil litigation it includes for the Sackler family that owns the drugmaker. Judge Colleen McMahon has thrown out the plan in a New York court, in a move that would remove the shield handed to the Sackers in return for a $4.5 billion payout to projects intended to support victims of the opioid crisis over a nine-year period.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
DECEMBER 14, 2021
Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland for patients who have previously failed fluoropyrimidine-based chemotherapy.
Outsourcing Pharma
DECEMBER 15, 2021
The Parkinsonâs Progression Markers Initiative, built using Evidation Healthâs research platform, aims to triple enrollment and recruit online participants.
Fierce Healthcare
DECEMBER 16, 2021
KFF poll: Half of US adults avoided care in the past year due to costs. agliadkovskaya. Thu, 12/16/2021 - 13:51.
pharmaphorum
DECEMBER 15, 2021
Bristol-Myers Squibb’s rheumatoid arthritis drug Orencia has been approved by the FDA to prevent graft versus host disease (GvHD), a serious complication of haematopoietic stem cell transplant (HSCT) used to treat leukaemias and other blood cancers. Orencia (abatacept) becomes the first drug to be approved to prevent GvHD , a condition in which donor immune cells attack tissues in the patient receiving an HSCT, commonly known as a bone marrow transplant.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Times
DECEMBER 15, 2021
Omicron has been the latest variant to test the effectiveness of COVID-19 vaccines.
Outsourcing Pharma
DECEMBER 13, 2021
The pharma firm has gifted $1m USD to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.
Fierce Healthcare
DECEMBER 16, 2021
Federal appeals court revives Biden's vaccine mandate for health workers in 26 states. hlandi. Thu, 12/16/2021 - 16:52.
pharmaphorum
DECEMBER 13, 2021
It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. One of its other scientific legacies was the specific development and approval of mRNA vaccines, the first in that drug class on the market.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
DECEMBER 16, 2021
A warning has been issued to UK MPs from the head of NHS England that hospitalisations could exceed numbers recorded in January 2021.
Outsourcing Pharma
DECEMBER 17, 2021
The company has released a survey of cancer doctors; 83% of those polled believe real-world data is crucial to accelerating cancer research and treatment.
Fierce Healthcare
DECEMBER 14, 2021
HHS to distribute $9B in COVID-19 relief funds to smaller providers this week. rking. Tue, 12/14/2021 - 11:31.
pharmaphorum
DECEMBER 14, 2021
Novartis as opted out of a collaboration with Mesoblast to develop its stem cell-based therapy remestemcel-L as a treatment for COVID-19, prompting a slump in the biotech’s share price. Novartis agreed to pay $25 million upfront for opt-in rights to remestemcel-L just over a year ago and to make a $25 million equity stake in Mesoblast, with up to $1.25 billion in additional payments tied to regulatory and commercial objectives.
Pharma Marketing Network
DECEMBER 17, 2021
#1: Omnichannel engagement is the key to creating personalized customer experiences and relevancy, but it remains something of a holy grail within the pharmaceutical industry. Across several sessions at this year’s Reuters Pharma Marketing USA, leading marketers discussed why it’s been such an uphill struggle and shared possible solutions. Traditionally, pharmaceutical companies have been siloed to a degree that would be unthinkable in most other industries.
Outsourcing Pharma
DECEMBER 14, 2021
Novartis has introduced its T-Charge platform at ASH 2021, which it says will serve as the foundation for various new investigational CAR-T cell therapies in its pipeline.
Fierce Healthcare
DECEMBER 15, 2021
CMS actuaries: Healthcare expenditures spiked 9.7% in 2020 amid COVID-19 response. pminemyer. Wed, 12/15/2021 - 16:28.
pharmaphorum
DECEMBER 17, 2021
There is no doubt that the COVID-19 pandemic has accelerated the adopt of digital health. As this issue’s contributors discuss, the rapid transition to digital has showcase the potential of technology across the industry, but how can we continue this momentum beyond the pandemic? Read on for a look at some of the biggest stories from Frontiers Health, how digital is making healthcare more patient-friendly and key ways to optimise decentralised clinical trials.
Pharma Mirror
DECEMBER 16, 2021
Impaired driving due to prescription medication is often given less attention than driving under the influence of illegal drugs. Yet, prescription drugs are just as dangerous, if not more dangerous, because many people are either not aware of the drug’s influence on their driving or assume prescribed medication is “safe.” Some medication, however, significantly increases the risk of car crashes.
Outsourcing Pharma
DECEMBER 14, 2021
The US agency continues to work with industry professionals on vaccines and treatments for the virus, and to wrestle with current and emerging variants.
Fierce Healthcare
DECEMBER 15, 2021
Moody's: Outlook stable for insurers in 2022, but COVID-19's effects could linger. pminemyer. Wed, 12/15/2021 - 13:27.
pharmaphorum
DECEMBER 17, 2021
After three years of availability via the Cancer Drugs Fund (CDF), MSD’s checkpoint inhibitor Keytruda has now been approved for routine NHS use after surgery for people with melanoma to prevent the cancer returning. PD-1 inhibitor Keytruda (pembrolizumab) has been recommended by NICE for adjuvant treatment of adults with stage 3 melanoma that has spread to the lymph nodes, aiming to remove any cancer left behind after surgery.
indispensable health
DECEMBER 15, 2021
An Interview With Paula Styer, Licensed Pharmacy Technician (LPhT). What Is Your Name and Job Title? Well, my name is Paula Styler and I am a pharmacy technician. I have been a pharmacy technician since 2008. When Did You Become Interested in Pharmacy? I had been working in photography for a very long time, and the studio I worked for closed. I was unemployed for about a year and a half to two years.
Outsourcing Pharma
DECEMBER 16, 2021
Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.
Fierce Healthcare
DECEMBER 17, 2021
CMS: Insurers paid out $2B in medical loss ratio rebates for 2020 claims. rking. Fri, 12/17/2021 - 16:06.
Expert insights. Personalized for you.
145 
Let's personalize your content